Austin Murata

Array ( [id] => 5241766 [patent_doc_number] => 20070020258 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-25 [patent_title] => 'Immunoglobulin variants' [patent_app_type] => utility [patent_app_number] => 11/527969 [patent_app_country] => US [patent_app_date] => 2006-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 21565 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20070020258.pdf [firstpage_image] =>[orig_patent_app_number] => 11527969 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5253233 [patent_doc_number] => 20070134689 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-14 [patent_title] => 'Tumor marker for ovarian cancer diagnosis' [patent_app_type] => utility [patent_app_number] => 11/532079 [patent_app_country] => US [patent_app_date] => 2006-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3768 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0134/20070134689.pdf [firstpage_image] =>[orig_patent_app_number] => 11532079 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4994182 [patent_doc_number] => 20070009527 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-11 [patent_title] => 'Method for cloning of variable domain sequences' [patent_app_type] => utility [patent_app_number] => 11/519750 [patent_app_country] => US [patent_app_date] => 2006-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9038 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20070009527.pdf [firstpage_image] =>[orig_patent_app_number] => 11519750 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5604268 [patent_doc_number] => 20060294615 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-28 [patent_title] => 'Therapeutic and diagnostic applications of prostatic acid phosphatase in prostate cancer' [patent_app_type] => utility [patent_app_number] => 11/507256 [patent_app_country] => US [patent_app_date] => 2006-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 20895 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0294/20060294615.pdf [firstpage_image] =>[orig_patent_app_number] => 11507256 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4530264 [patent_doc_number] => 07923538 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-04-12 [patent_title] => 'Recombinant antibody composition' [patent_app_type] => utility [patent_app_number] => 11/491501 [patent_app_country] => US [patent_app_date] => 2006-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 49780 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/923/07923538.pdf [firstpage_image] =>[orig_patent_app_number] => 11491501 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7545590 [patent_doc_number] => 08053562 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-08 [patent_title] => 'Modified antibody fragments' [patent_app_type] => utility [patent_app_number] => 11/995740 [patent_app_country] => US [patent_app_date] => 2006-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9346 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 130 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/053/08053562.pdf [firstpage_image] =>[orig_patent_app_number] => 11995740 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5602300 [patent_doc_number] => 20060292645 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-28 [patent_title] => 'Method and reagent for measuring kinase activity' [patent_app_type] => utility [patent_app_number] => 11/473550 [patent_app_country] => US [patent_app_date] => 2006-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4673 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0292/20060292645.pdf [firstpage_image] =>[orig_patent_app_number] => 11473550 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5153915 [patent_doc_number] => 20070036798 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-15 [patent_title] => 'Method and composition for reconforming multi-epitopic antigens to initiate an immune response' [patent_app_type] => utility [patent_app_number] => 11/472808 [patent_app_country] => US [patent_app_date] => 2006-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10822 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0036/20070036798.pdf [firstpage_image] =>[orig_patent_app_number] => 11472808 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5230285 [patent_doc_number] => 20070292392 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-20 [patent_title] => 'USE OF THYMOSIN ALPHA 1 FOR PREPARING A MEDICAMENT FOR THE TREATMENT OF STAGE IV MALIGNANT MELANOMA' [patent_app_type] => utility [patent_app_number] => 11/424475 [patent_app_country] => US [patent_app_date] => 2006-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3402 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0292/20070292392.pdf [firstpage_image] =>[orig_patent_app_number] => 11424475 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5495354 [patent_doc_number] => 20090263382 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-22 [patent_title] => 'STABLE AND SOLUBLE ANTIBODIES INHIBITING TNF ALPHA' [patent_app_type] => utility [patent_app_number] => 11/916793 [patent_app_country] => US [patent_app_date] => 2006-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 17590 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20090263382.pdf [firstpage_image] =>[orig_patent_app_number] => 11916793 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5153914 [patent_doc_number] => 20070036797 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-15 [patent_title] => 'Methods of treating brain tumors with antibodies' [patent_app_type] => utility [patent_app_number] => 11/446045 [patent_app_country] => US [patent_app_date] => 2006-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8590 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0036/20070036797.pdf [firstpage_image] =>[orig_patent_app_number] => 11446045 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7703153 [patent_doc_number] => 08088908 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-03 [patent_title] => 'Humanized anti-prostate stem cell antigen monoclonal antibody' [patent_app_type] => utility [patent_app_number] => 11/432304 [patent_app_country] => US [patent_app_date] => 2006-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11718 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/088/08088908.pdf [firstpage_image] =>[orig_patent_app_number] => 11432304 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5440973 [patent_doc_number] => 20090092612 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-09 [patent_title] => 'ANTI-PLATELET MEMBRANE GLYCOPROTEIN VI MONOCLONAL ANTIBODY' [patent_app_type] => utility [patent_app_number] => 11/912757 [patent_app_country] => US [patent_app_date] => 2006-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 48 [patent_figures_cnt] => 48 [patent_no_of_words] => 45955 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20090092612.pdf [firstpage_image] =>[orig_patent_app_number] => 11912757 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5435546 [patent_doc_number] => 20090170133 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-02 [patent_title] => 'Intact IGFBP-3 as a Colon Cancer Risk Factor in Patients With Inflammatory Bowel Disease' [patent_app_type] => utility [patent_app_number] => 11/918337 [patent_app_country] => US [patent_app_date] => 2006-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5251 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20090170133.pdf [firstpage_image] =>[orig_patent_app_number] => 11918337 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5142693 [patent_doc_number] => 20070004909 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-04 [patent_title] => 'Covalent diabodies and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/409339 [patent_app_country] => US [patent_app_date] => 2006-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 68231 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20070004909.pdf [firstpage_image] =>[orig_patent_app_number] => 11409339 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5732834 [patent_doc_number] => 20060257951 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-16 [patent_title] => 'Use of protein spee as a marker for breast cancer' [patent_app_type] => utility [patent_app_number] => 11/404216 [patent_app_country] => US [patent_app_date] => 2006-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7956 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0257/20060257951.pdf [firstpage_image] =>[orig_patent_app_number] => 11404216 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4662725 [patent_doc_number] => 20080253632 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-16 [patent_title] => 'Method of Detecting Precancerous Lesions' [patent_app_type] => utility [patent_app_number] => 11/910016 [patent_app_country] => US [patent_app_date] => 2006-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 8883 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0253/20080253632.pdf [firstpage_image] =>[orig_patent_app_number] => 11910016 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10069527 [patent_doc_number] => 09107863 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-08-18 [patent_title] => 'Reagents and methods for cancer treatment and prevention' [patent_app_type] => utility [patent_app_number] => 11/389695 [patent_app_country] => US [patent_app_date] => 2006-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 9578 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11389695 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7515522 [patent_doc_number] => 08039594 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-10-18 [patent_title] => 'Human synthetic single-chain antibodies directed against the common epitope of mutant P53 and their uses' [patent_app_type] => utility [patent_app_number] => 11/887123 [patent_app_country] => US [patent_app_date] => 2006-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 80 [patent_no_of_words] => 26506 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 130 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/039/08039594.pdf [firstpage_image] =>[orig_patent_app_number] => 11887123 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5784342 [patent_doc_number] => 20060204510 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-14 [patent_title] => 'Bv8 nucleic acids and polypeptides with mitogenic activity' [patent_app_type] => utility [patent_app_number] => 11/384222 [patent_app_country] => US [patent_app_date] => 2006-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 32866 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0204/20060204510.pdf [firstpage_image] =>[orig_patent_app_number] => 11384222 [rel_patent_id] =>[rel_patent_doc_number] =>)